1. Bartelink H (1987) Combined modality treatment for the primary tumour. National Cancer Institute Monographs (in press)
2. Bartelink H, Kallman RF, Rapachietta D, Hart GAM (1986) Therapeutic enhancement in mice by clinically relevant dose and fractionation schedules of cis-diamminedichloroplatinum (II) and irradiation. Radiother Oncol 6: 61–74
3. Begg AC, van der Kolk PJ, Dewit L, Bartelink H (1986) Radiosensitization by cisplatin of RIF-1 tumour cells in vitro. Int J Radiat Biol 50: 871–884
4. Begg AC, Bartelink H, Stewart FA, Brown DM, Luck EE (1987) Improvement of differential toxicity between tumor and normal tissues using intratumoral injections with and without a slow drug release matrix system. National Cancer Institute Monographs (in press)
5. Bergerat JP, Barlogie B, Gohde W, Johnston DA, Drewinko B (1979) In vitro cytokinetic response of human colon cancer cells to cis-diamminedichloroplatinum (II). Cancer Res 39: 4356–4363